1-3 of 3
Rasmus Heje Thomsen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FORTITUDE: A Phase 2 Open-Label Study in Progress to Evaluate Etavopivat for the Treatment of Anemia in Patients with Lower-Risk Myelodysplastic Syndromes

Free
Mikkael A. Sekeres, Uwe Platzbecker, Rasmus Heje Thomsen, Sam Wilson, Anne S. Renteria, Pierre Fenaux
Journal: Blood
Blood (2023) 142 (Supplement 1): 3251.
https://doi.org/10.1182/blood-2023-180644
Published: 2023
Journal Articles

Real-World Outcomes for 205 Danish Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib

Free
Kathrine Aarup, Lisbeth Enggaard, MD, Robert Schou Pedersen, MD PhD, Rasmus Heje Thomsen, Olav Jonas Bergmann, Mikael Frederiksen, Ilse Christiansen, Tine Nielsen, Henrik Frederiksen, MD Prof, Carsten Utoft Niemann, MD PhD Ass. Prof, Michael Asger Andersen, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1767.
https://doi.org/10.1182/blood-2019-123011
Published: 2019
Journal Articles

Prognostic Factors for Patients with Diffuse Large B Cell Lymphoma and Transformed Indolent Lymphoma Undergoing Autologous Stem Cell Transplantation in Denmark 2000-2012

Free
Bente Arboe, Kristina Fruerlund Nielsen, Charlotte Madsen, Rasmus Heje Thomsen, Soeren Ramme Nielsen, Jette Soenderskov Goerloev, Peter de Nully Brown, MDPhD
Journal: Blood
Blood (2015) 126 (23): 1983.
https://doi.org/10.1182/blood.V126.23.1983.1983
Published: 2015